FIELD: medicine; chemistry.
SUBSTANCE: invention relates to chemistry and medicine and can be used in the manufacture of medicines and cosmetics. First crystalline fullerene, for example C60, dissolved in N-methylpyrrolidone. Resulting solution is mixed with water or an aqueous solution of a stabilizer, which is used as a biocompatible non-ionic surfactant, monosaccharide and / or amino acid, pluronic F-127, L-alanine, rhamnose, glycerin, twin 20 and / or twin 80. This is followed by tangential in-line ultrafiltration of the resulting solution using a semipermeable polysulfone or regenerated cellulose membrane. Excessive dialysis can be performed before ultrafiltration.
EFFECT: invention provides a high colloidal stability of the resulting aqueous solution of fullerene in the presence of salts in the range of fullerene concentrations of 50–3,000 mg/l.
7 cl, 8 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF FULLERENE WATER-SALT DISPERSIONS | 2015 |
|
RU2630561C2 |
APPLICATION OF FULLERENE C60 AQUEOUS SOLUTION AS THERAPEUTIC AGENT AT ATOPIC DERMATITIS DISEASE | 2016 |
|
RU2641091C1 |
METHOD FOR PRODUCING AQUEOUS NANODISPERSIONS OF FULLEREN | 2013 |
|
RU2548971C2 |
METHOD OF PRODUCING FULLERENE ADDUCTS | 2010 |
|
RU2462474C2 |
WATER-SOLUBLE NANOCOMPOSITES WITH FULLERENE C NANOPARTICLES IN POLY-N-VINYLPYRROLIDONE MATRIX AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2823484C1 |
COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
HEPATOPROTECTIVE AND ANTIOXIDANT DRUG FOR ANIMALS BASED ON AQUEOUS SOLUTION OF FULLERENE C, RESVERATROL AND BETAINE HYDROCHLORIDE | 2020 |
|
RU2770534C1 |
USE OF FULLERENOLS C60(OH)18-24 AND C60(OH)30-38 AS ANTIVIRAL PREPARATIONS | 2011 |
|
RU2472496C2 |
METHOD OF PRODUCING CONCENTRATED AQUEOUS DISPERSIONS OF NON-MODIFIED FULLERENES | 2014 |
|
RU2570083C1 |
PHARMACEUTICAL COMPOSITION FOR PHOTODYNAMIC TREATMENT AND METHOD OF TREATMENT OF ONCOLOGY DISEASES WITH USE OF COMPOSITION | 2005 |
|
RU2323722C2 |
Authors
Dates
2019-02-06—Published
2018-01-17—Filed